Aimmune Therapeutics

Member for

10 months 1 week
HCP ID number type
CRM
Notifications
On
Profile Complete
On
Submitted by Mykhailo.Kater… on Tue, 05/24/2022 - 10:34
Aimmune Therapeutics is a biopharmaceutical business unit developing and commercializing treatments for potentially life-threatening food allergies. Aimmune’s Palforzia is the first and only FDA and EMA-approved treatment to help reduce the frequency and severity of allergic reactions to peanuts, including anaphylaxis, in children aged 4 through 17.
Choose partners
Image
aimmune-therapeutics-logo-vector.jpg